Miracle Mile Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.62M | Buy |
233,380
+5,085
| +2% | +$133K | 0.07% | 194 |
|
|
2026
Q1 | $6.41M | Sell |
228,295
-6,508
| -3% | -$173K | 0.09% | 162 |
|
|
2025
Q4 | $5.85M | Sell |
234,803
-1,456
| -0.6% | -$36.7K | 0.08% | 168 |
|
|
2025
Q3 | $6.02M | Buy |
236,259
+804
| +0.3% | +$19.8K | 0.09% | 154 |
|
|
2025
Q2 | $5.71M | Buy |
235,455
+2,221
| +1% | +$51.8K | 0.1% | 142 |
|
|
2025
Q1 | $5.91M | Buy |
233,234
+13,534
| +6% | +$354K | 0.12% | 118 |
|
|
2024
Q4 | $5.83M | Buy |
219,700
+22,097
| +11% | +$599K | 0.12% | 122 |
|
|
2024
Q3 | $5.72M | Buy |
197,603
+1,583
| +0.8% | +$46.2K | 0.13% | 100 |
|
|
2024
Q2 | $5.48M | Buy |
196,020
+3,028
| +2% | +$83.4K | 0.13% | 98 |
|
|
2024
Q1 | $5.36M | Buy |
192,992
+168,369
| +684% | +$4.67M | 0.13% | 105 |
|
|
2023
Q4 | $709K | Sell |
24,623
-2,144
| -8% | -$64.8K | 0.02% | 298 |
|
|
2023
Q3 | $888K | Sell |
26,767
-1,274
| -5% | -$45.1K | 0.03% | 265 |
|
|
2023
Q2 | $1.03M | Sell |
28,041
-390
| -1% | -$15.2K | 0.03% | 255 |
|
|
2023
Q1 | $1.16M | Buy |
28,431
+1,692
| +6% | +$73.1K | 0.04% | 253 |
|
|
2022
Q4 | $1.37M | Sell |
26,739
-1,104
| -4% | -$52.9K | 0.05% | 235 |
|
|
2022
Q3 | $1.22M | Buy |
27,843
+5,557
| +25% | +$270K | 0.06% | 190 |
|
|
2022
Q2 | $1.17M | Buy |
22,286
+4,038
| +22% | +$206K | 0.05% | 208 |
|
|
2022
Q1 | $945K | Sell |
18,248
-3,449
| -16% | -$179K | 0.04% | 248 |
|
|
2021
Q4 | $1.28M | Sell |
21,697
-9,201
| -30% | -$456K | 0.05% | 221 |
|
|
2021
Q3 | $1.33M | Sell |
30,898
-36,976
| -54% | -$1.64M | 0.06% | 206 |
|
|
2021
Q2 | $2.66M | Sell |
67,874
-1,594
| -2% | -$62K | 0.14% | 128 |
|
|
2021
Q1 | $2.52M | Buy |
69,468
+5,629
| +9% | +$200K | 0.14% | 128 |
|
|
2020
Q4 | $2.35M | Sell |
63,839
-1,266
| -2% | -$46.4K | 0.14% | 130 |
|
|
2020
Q3 | $2.27M | Sell |
65,105
-147,142
| -69% | -$5.16M | 0.16% | 124 |
|
|
2020
Q2 | $6.58M | Buy |
212,247
+102,175
| +93% | +$3.47M | 0.54% | 44 |
|
|
2020
Q1 | $3.41M | Buy |
110,072
+47,790
| +77% | +$1.63M | 0.37% | 52 |
|
|
2019
Q4 | $2.31M | Buy |
62,282
+14,971
| +32% | +$533K | 0.16% | 107 |
|
|
2019
Q3 | $1.61M | Sell |
47,311
-5,888
| -11% | -$214K | 0.11% | 138 |
|
|
2019
Q2 | $2.19M | Buy |
53,199
+5,960
| +13% | +$237K | 0.16% | 114 |
|
|
2019
Q1 | $1.9M | Buy |
47,239
+37,292
| +375% | +$1.49M | 0.15% | 114 |
|
|
2018
Q4 | $412K | Buy |
9,947
+650
| +7% | +$27K | 0.05% | 98 |
|
|
2018
Q3 | $389K | Sell |
9,297
-2,592
| -22% | -$99.8K | 0.04% | 131 |
|
|
2018
Q2 | $409K | Buy |
11,889
+3,457
| +41% | +$118K | 0.04% | 123 |
|
|
2018
Q1 | $284K | Hold |
8,432
| – | – | 0.03% | 131 |
|
|
2017
Q4 | $290K | Buy |
+8,432
| New | +$288K | 0.05% | 84 |
|
Other funds holding PFE
AIM
CWP
FWIA
ORIO
CAI
Miracle Mile Advisors's PFE Position: Q2 2026 in Review
Miracle Mile Advisors increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $133K and bringing the position to 233,380 shares worth $5.62M. The position accounts for 0.07% of the portfolio, ranked #194.
Miracle Mile Advisors first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $6.58M in Q2 2020. 727 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Miracle Mile Advisors held 233,380 shares of Pfizer worth $5.62M as of Q2 2026.
- Miracle Mile Advisors bought 5,085 Pfizer shares in Q2 2026, an estimated $133K.
- Pfizer made up 0.07% of Miracle Mile Advisors's portfolio in Q2 2026, its #194 holding.
- Miracle Mile Advisors first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Miracle Mile Advisors's Pfizer position peaked at $6.58M in Q2 2020.
- 727 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.